Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Alain Bergeron
Affiliation
Centre de recherche sur le cancer de l'Universite Laval
ORCID
Career Start Year
1990
Papers
48
H Index
19
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36343786
UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.
Cancer Lett
2023
37190147
Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study.
Cancers (Basel)
2023
37086156
Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.
Mol Oncol
2023
37435060
High infiltration of CD209<sup>+</sup> dendritic cells and CD163<sup>+</sup> macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.
Front Immunol
2023
35075795
Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor-associated macrophage phenotype.
Clin Transl Med
2022
35598879
Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion.
Mol Metab
2022
36246841
Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment.
Eur Urol Open Sci
2022
32676741
Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival.
World J Urol
2021
34944863
Identification of Morphologic Criteria Associated with Biochemical Recurrence in Intraductal Carcinoma of the Prostate.
Cancers (Basel)
2021
34588590
Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs.
Sci Rep
2021
34575920
Identification of Abundant and Functional dodecaRNAs (doRNAs) Derived from Ribosomal RNA.
Int J Mol Sci
2021
34743445
Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.
J Biomed Opt
2021
33276284
Long chain omega-3 fatty acids and their oxidized metabolites are associated with reduced prostate tumor growth.
Prostaglandins Leukot Essent Fatty Acids
2021
33262291
Omega-3 Eicosapentaenoic Acid Reduces Prostate Tumor Vascularity.
Mol Cancer Res
2021
32797086
Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.
PLoS Med
2020
33299664
Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression.
Oncoimmunology
2020
33324443
Identification of a Transcriptomic Prognostic Signature by Machine Learning Using a Combination of Small Cohorts of Prostate Cancer.
Front Genet
2020
30735634
Widespread and Functional RNA Circularization in Localized Prostate Cancer.
Cell
2019
30073695
Omega-3 fatty acids decrease prostate cancer progression associated with an anti-tumor immune response in eugonadal and castrated mice.
Prostate
2019
31265453
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.
PLoS Med
2019
31591588
Genome-wide germline correlates of the epigenetic landscape of prostate cancer.
Nat Med
2019
31018850
Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.
Radiat Oncol
2019
31156708
Large-Scale Automatic Feature Selection for Biomarker Discovery in High-Dimensional OMICs Data.
Front Genet
2019
28972698
Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors.
BJU Int
2018
30200929
The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation.
BMC Urol
2018
29603326
The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival.
Prostate
2018
28068672
Genomic hallmarks of localized, non-indolent prostate cancer.
Nature
2017
28511883
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.
Eur Urol
2017
27815082
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.
Eur Urol
2017
26759009
Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancer.
Cancer Immunol Immunother
2016
26645279
Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.
Cancer Prev Res (Phila)
2016
27604597
Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer.
Cancer Immunol Res
2016
24892030
IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressiveness.
Res Rep Urol
2014
25371605
Cystatin C for early detection of acute kidney injury after laparoscopic partial nephrectomy.
Urol Ann
2014
23574787
High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.
Hum Pathol
2013
23979666
Toll-like receptors in urothelial cells--targets for cancer immunotherapy.
Nat Rev Urol
2013
21421234
Toll-like receptors in normal and malignant human bladders.
J Urol
2011
19193487
Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
Eur Urol
2009
19533752
High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer.
Int J Cancer
2009
17290406
MAGE-A9 mRNA and protein expression in bladder cancer.
Int J Cancer
2007
16516037
Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.
J Urol
2006
17069033
Cancer-testis antigen expression in bladder cancer.
Prog Urol
2006
16734221
Cancer-testis antigen expression in bladder cancer.
Prog Urol
2005
9032480
Biochemical analysis of a bladder-cancer-associated mucin: structural features and epitope characterization.
Biochem J
1997
9185702
Influence of spatial configuration on the expression of carcinoembryonic antigen and mucin antigens in human bladder cancer.
Int J Cancer
1997
8631032
Identification of a superficial bladder tumor-associated glycoform of the carcinoembryonic antigen by monoclonal antibody 19A211.
Cancer Res
1996
8636121
MAUB is a new mucin antigen associated with bladder cancer.
J Biol Chem
1996
1701166
Monoclonal antibody against a tumor-associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomas.
Int J Cancer
1990
1 - 48 of 48
Column Actions
Search
Recommended Authors
Stephanie A Wankowicz
University of California San Francisco
Career Start Year
2014
Number of shared co-authors
1
Ekaterina Olkhov-Mitsel
University of Toronto
Career Start Year
2012
Number of shared co-authors
11
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year
2008
Number of shared co-authors
14
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year
2007
Number of shared co-authors
9
Michelle R Downes
University of Toronto
Career Start Year
2006
Number of shared co-authors
16
Robert H Bell
University of British Columbia
Career Start Year
2004
Number of shared co-authors
9
Michiel S van der Heijden
the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
Career Start Year
2002
Number of shared co-authors
11
Robert Kim
University of California
Career Start Year
1996
Number of shared co-authors
2
J??rn Kamradt
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year
1996
Number of shared co-authors
0
Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
Career Start Year
1995
Number of shared co-authors
3
David Clouston
Career Start Year
1995
Number of shared co-authors
18
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year
1994
Number of shared co-authors
12
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year
1993
Number of shared co-authors
19
Bhaskar Kallakury
Georgetown University
Career Start Year
1993
Number of shared co-authors
0
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year
1992
Number of shared co-authors
9
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year
1990
Number of shared co-authors
16
Colin P Dinney
The University of Texas MD Anderson Cancer Center
Career Start Year
1990
Number of shared co-authors
8
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year
1989
Number of shared co-authors
3
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1989
Number of shared co-authors
14
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year
1988
Number of shared co-authors
9
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year
1988
Number of shared co-authors
1
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year
1987
Number of shared co-authors
19
Jolanta Bondaruk
The University of Texas MD Anderson Cancer Center
Career Start Year
1985
Number of shared co-authors
0
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year
1984
Number of shared co-authors
8
Francisco X Real
Spanish National Cancer Research Centre-CNIO
Career Start Year
1983
Number of shared co-authors
11
David M Berman
Queen's University
Career Start Year
1982
Number of shared co-authors
31
Lawrence D True
University of Washington School of Medicine
Career Start Year
1980
Number of shared co-authors
13
Timothy L Ratliff
Purdue University
Career Start Year
1978
Number of shared co-authors
0
Herbert Barton Grossman
University of Texas MD Anderson Cancer Center
Career Start Year
1977
Number of shared co-authors
2
Bogdan Czerniak
University of Texas MD Anderson Cancer Center
Career Start Year
1975
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers
44
Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers
20
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers
19
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers
12
Val??rie Picard
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers
12
Dominique Trudel
Institut du cancer de Montreal
Co-authored papers
10
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers
10
Fred Saad
University of Montreal Health Center
Co-authored papers
8
Paul C Boutros
University of California los angeles
Co-authored papers
8
Robert G Bristow
University of Toronto
Co-authored papers
8
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
7
Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Co-authored papers
7
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Co-authored papers
7
Arnaud Droit
Centre de Recherche du CHU de Quebec-Universite, Universite Laval
Co-authored papers
5
Julie Livingstone
University of California los angeles
Co-authored papers
5
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers
5
Neil E Fleshner
University of Toronto
Co-authored papers
5
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Co-authored papers
5
Herv?? Brisson
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Co-authored papers
4
Nazim Benzerdjeb
Institut de Pathologie Multisite
Co-authored papers
4
Andr??e-Anne Grosset
Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM)
Co-authored papers
4
Colin C Collins
University of British Columbia
Co-authored papers
4
Andr?? Kougioumoutzakis
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers
4
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers
3
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers
3
Martin E Gleave
University of British Columbia
Co-authored papers
3
Simone Chevalier
McGill University Health Centre, McGill University
Co-authored papers
3
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers
3
Mickael Leclercq
CHU de Quebec-Laval University Research Center
Co-authored papers
3
Alice Meng
Tufts University School of Medicine
Co-authored papers
3
1 - 30